多发性硬化症药物依从性对复发、残疾和医疗费用影响的简明语言总结
基于美国MS患者保险索赔数据，分析药物依从性对复发、残疾和医疗费用的影响。
基本信息
资源简介
多发性硬化症药物依从性对复发、残疾和医疗费用影响的简明语言总结
【一句话概览】
本数据集是 figshare 公开的结构化表格数据集，收录 2 个文件、合计 27.04 KB，主题涵盖 researchers evaluated insurance、plain language summary、might impact long、higher relapse rates、wheelchair use compared，可用于统计建模、特征工程与队列分析，CC BY 4.0 许可开放获取。
【数据集背景】
本数据集源站标题为《A plain language summary on taking medication as prescribed for multiple sclerosis: impact on relapses, disability, and healthcare costs》。配套论文《A plain language summary on taking medication as prescribed for multiple sclerosis: impact on relapses, disability, and healthcare costs》发表于 Neurodegenerative Disease Management（2025），DOI：10.1080/17582024.2025.2506949。源站首次发布：2025-11-14。
【数据内容】
源站原始描述：What is this summary about? People with multiple sclerosis (MS) may struggle to take their medication as prescribed (treatment adherence), which might impact long-term disease outcomes and healthcare costs. To understand more about the relationship between treatment adherence and disease/cost outcomes, the researchers evaluated insurance claims in the United States from more than 8000 adults with MS between 2011 and 2017. How was the analysis carried out? In this analysis, researchers compared M…
中文译文（机器翻译，仅供快速理解，请以原文为准）：这个摘要讲的是什么？ 多发性硬化症（MS）患者可能难以按处方用药（治疗依从性），这可能会影响长期疾病结局和医疗费用。为了更好地了解治疗依从性与疾病/费用结局之间的关系，研究人员评估了2011年至2017年间美国8000多名MS成人的保险索赔数据。 分析是如何进行的？ 在这项分析中，研究人员比较了按处方用药者（依从者）和未按处方用药者（不依从者）的MS疾病复发率、残疾指标（如使用手杖、助行器或轮椅）以及医疗费用。 结果是什么？ 与依从用药的MS患者相比，不依从处方用药的MS患者复发率更高，且首次复发、使用手杖或助行器以及使用轮椅的时间更短。此外，不依从者的总体医疗费用高于依从者。 结果意味着什么？ 这些发现表明，不依从MS处方治疗会增加复发风险、需要手杖、助行器或轮椅的风险以及医疗费用。
【数据结构与技术规格】
文件数 2 个，合计 27.04 KB。Multiple Sclerosis.m4a：audio/mp4，17.13 KB。Relapse.m4a：audio/mp4，9.91 KB。数据集 DOI：10.6084/m9.figshare.30621380.v1。
【主题与分类】
源站学科分类：Biophysics、Medicine、Pharmacology、Biotechnology、Sociology、Science Policy。主题标签：researchers evaluated insurance、plain language summary、might impact long、higher relapse rates、wheelchair use compared、term disease outcomes、treatment adherence ),、wheelchair use、cost outcomes、treatment adherence。
【适用方向】
结构化表格数据可直接用于统计建模、特征工程与队列分析。
【获取与许可】
源站页面：https://tandf.figshare.com/articles/dataset/A_plain_language_summary_on_taking_medication_as_prescribed_for_multiple_sclerosis_impact_on_relapses_disability_and_healthcare_costs/30621380
使用许可：CC BY 4.0（https://creativecommons.org/licenses/by/4.0/）。
规范引用：A plain language summary on taking medication as prescribed for multiple sclerosis: impact on relapses, disability, and healthcare costs. Taylor & Francis. Amezcua, Lilyana; Livingston, Terrie; Hayward, Brooke; Zhou, Jia; Williams, Mitzi J
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载，适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档，适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务（收技术服务费，非数据销售）
暂未开放当前数据集主要来源为 Kaggle 公开托管，完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取（Figshare）
- 源站标题：A plain language summary on taking medication as prescribed for multiple sclerosis: impact on relapses, disability, and healthcare costs
- DOI：10.6084/m9.figshare.30621380.v1
- 发布日期：2025-11-14
- 文件数：2 个
- 文件总体积：27.04 KB
- 源站页面：https://tandf.figshare.com/articles/dataset/A_plain_language_summary_on_taking_medication_as_prescribed_for_multiple_sclerosis_impact_on_relapses_disability_and_healthcare_costs/30621380
命令行下载
curl -L -o "Multiple Sclerosis.m4a" "https://ndownloader.figshare.com/files/59566445"
curl -L -o "Relapse.m4a" "https://ndownloader.figshare.com/files/59566448"
文件清单
Multiple Sclerosis.m4a（17.13 KB）Relapse.m4a（9.91 KB）
文件总体积 27.04 KB（源站 API 实测）。
数据加载示例（图像类）
from PIL import Image
import glob, os
files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)
# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path) # 要求 子目录=类别
目录组织与标注格式以源站说明和下载后实际文件为准。
数据说明
What is this summary about?
People with multiple sclerosis (MS) may struggle to take their medication as prescribed (treatment adherence), which might impact long-term disease outcomes and healthcare costs. To understand more about the relationship between treatment adherence and disease/cost outcomes, the researchers evaluated insurance claims in the United States from more than 8000 adults with MS between 2011 and 2017.
How was the analysis carried out?
In this analysis, researchers compared MS disease relapse rates and indicators of disability such as the use of canes, walkers, or wheelchairs as well as healthcare costs among people who took their medication as prescribed (were adherent) and those who did not (were non-adherent).
What were the results?
People with MS who were non-adherent to their prescribed medication had higher relapse rates and shorter times to first relapse, cane or walker use, and wheelchair use compared with people who were adherent to their medication. Also, people who were non-adherent had higher overall healthcare costs than those who were adherent.
What do the results mean?
These findings suggest that non-adherence to treatment prescribed for MS increases the risk of relapse, need for cane, walker, or wheelchair use, and healthcare costs.
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.6084/m9.figshare.30621380.v1（source: https://tandf.figshare.com/articles/dataset/A_plain_language_summary_on_taking_medication_as_prescribed_for_multiple_sclerosis_impact_on_relapses_disability_and_healthcare_costs/30621380）。
数据缺失？
依托陕西、四川两大基地，我们与超过十家三甲医院建立直接合作关系，覆盖合规授权、采集治理、专业标注、数据交付的全流程，为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务？立即联系我们获取专业方案。
